ICU infectious disease
Conditions
Interventions
Valid group and invalid group:None
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) the age of the patient is = 18 years old. (2) ICU patients treated with colistin sulfate for injection. (3) informed consent signed by the patient or his legal representative
Exclusion criteria
Exclusion criteria: (1) pregnant and lactating women. (2) patients with less than 5 doses of colistin sulfate for injection. (3) patients who received other polymyxin treatment 7 days before inclusion. (4) those who are known to be allergic to colistin sulfate. (5) it has been included in other clinical studies, and intervention measures will affect the results of this study. (6) other situations in which the researchers consider it inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and safety of colistin sulfate in patients with ICU; | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU mortality rate;28 day outcome indicators;The incidence of acute renal insufficiency; | — |
Countries
China
Contacts
Public ContactZhongwei Zhang
West China Hospital, Sichuan University
Outcome results
None listed